Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma
Journal of Clinical Investigation · 01.07.2026 · 136 (13)
DOI: 10.1172/jci207473 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.07.2026. Verfasst von Raymond Ho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Lung Neoplasms, Adenocarcinoma, Cell Plasticity. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cells use plasticity programs to change lineages, which aids in tissue regeneration and remodeling but also allows aberrant cells to become cancerous and escape therapy. For example, tumor cells in invasive mucinous adenocarcinoma (IMA) emerge from lung epithelial cells by a plasticity program that reprograms them into gastric epithelium–like cells. In this issue of the JCI , Dadzie et al. show that hepatocyte nuclear factor 4 α (HNF4α) promotes gastric identity in lung epithelial cells via a mechanism involving restriction of FOXA1 and FOXA2 transcription factors to gastric gene enhancer loci. HNF4α also promotes resistance to KRAS inhibition by increasing nuclear factor erythroid 2–related factor 2 (NRF2) activity. These findings may advance therapeutic avenues in IMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
- Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.
Zitieren
APA
Ho, R., & Mills, J. C. (2026). Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma. Journal of Clinical Investigation, 136(13). https://doi.org/10.1172/jci207473
Vancouver
Ho R, Mills JC. Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma. Journal of Clinical Investigation. 2026;136(13). doi:10.1172/jci207473
BibTeX
@article{Ho2026,
author = {Ho, Raymond and Mills, Jason C},
title = {Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {13},
doi = {10.1172/jci207473}
}
EUVIMED